-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
Selegiline transdermal patch
Started by PsychFuture
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
Are you referring to a patch different from the one which was approved in March of this year (EMSAM). It is now approved, but won't be distributed to all wholesalers until later this year.
I asked about this a few months ago...it is effective, but the side effects which limit oral dosing are apparent at all but the lowest patch strength (there are 3 I think) which will limit its usefulness.
It is marketed by Bristol-Meyers Squibb so their site will have the references which were used for approval.
I asked about this a few months ago...it is effective, but the side effects which limit oral dosing are apparent at all but the lowest patch strength (there are 3 I think) which will limit its usefulness.
It is marketed by Bristol-Meyers Squibb so their site will have the references which were used for approval.
I have used the Emsam patch in a couple of patients. I have seen the copy from the FDA of the approve new drug application for the Emsam patch. I am looking for the original application that was declined due to lack of efficacy in 3 out of 4trials that were used to support the new drug application in 2001.
Advertisement - Members don't see this ad
PsychFuture said:
It's likely in the BMS internal data files. Did you try the FDA website?
I searched the FDAwebsite and could only find the second approved application and some back and forth about dietary guidelines.
Try this: search the fda.gov website for the NDA 21336/21708 or do a generic search for selegiline nda history.
The first NDA was submitted by Somerset Pharmaceuticals on 5-24-01 under nda 21-708.
This should get you started on the original studies. Only 1 of the 4 efficacy studies showed positive results for the first nda. I believe they were later redone with more convincing results.
The first NDA was submitted by Somerset Pharmaceuticals on 5-24-01 under nda 21-708.
This should get you started on the original studies. Only 1 of the 4 efficacy studies showed positive results for the first nda. I believe they were later redone with more convincing results.
